58 research outputs found

    Estudos sobre a nutrição mineral do arroz: XX - marcha de absorção de micronutrientes pelas variedades IAC-164 e IAC-165

    Get PDF
    Rice plants were grown in nutrient solution till the end of their life cycle. At given stages of development plant samples harvested for the determination of dry matter and micronutrient contents in the various organs. The following conclusions were drawn: only Fe accumulation showed some degree of positive relation with dry matter production; the pattern of distribution of the elements among the plant parts was essentially the same, for both varieties; B, Cu and Fe tend to concentrate in the root system; no clear cut pattern of variation in leaf composition could be described throughout the plant life cycle; maximum rate of uptake took place between full tillering and panicle formation.Plantas de arroz, variedades IAC-164 e IAC-165 foram cultivadas em solução nutritiva até o fim do ciclo. Em estádios determinados do seu desenvolvimento foram colhidas amostras que depois de secas foram analisadas determinando-se B, Cu, Fe, Mn e Zn nos diversos órgãos. Os dados obtidos permitiram verificar que: somente a acumulação do Fe quando um para lelismo com a de matéria seca; o padrão da distribuição porcentual nos vários órgãos dos elementos analisados durante o ciclo foi o mesmo nas duas variedades verificando-se que B, Cu e Fe tendem a acumular-se mais nas raízes que na parte aérea o oposto acontecendo com o Mn e o Zn; não foram observadas variações consistentes nos teores foliares dos elementos durante o experimento; no período que vai do perfilhamento pleno até a formação da panícula foi em geral maior a velocidade de acumulação dos macronutrientes

    The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16

    Get PDF
    Autosomal dominant polycystic kidney disease (ADPKD) is a common genetic disorder that frequently results in renal fallure due to progressive cyst development. The major locus, PKD1, maps to 16p13.3. We identified a chromosome translocation associated with ADPKD that disrupts a gene (PBP) encoding a 14 kb transcript in the PKD1 candidate region. Further mutations of the PBP gene were found in PKD1 patients, two deletions (one a de novo event) and a splicing defect, confirming that PBP is the PKD1 gene. This gene is located adjacent to the TSC2 locus in a genomic region that is reiterated more proximally on 16p. The duplicate area encodes three transcripts substantially homologous to the PKD1 transcript. Partial sequence analysis of the PKD1 transcript shows that it encodes a novel protein whose function is at present unknown

    Vaccination with nanoparticles combined with micro-adjuvants protects against cancer.

    Get PDF
    Induction of strong T cell responses, in particular cytotoxic T cells, is a key for the generation of efficacious therapeutic cancer vaccines which yet, remains a major challenge for the vaccine developing world. Here we demonstrate that it is possible to harness the physiological properties of the lymphatic system to optimize the induction of a protective T cell response. Indeed, the lymphatic system sharply distinguishes between nanoscale and microscale particles. The former reaches the fenestrated lymphatic system via diffusion, while the latter either need to be transported by dendritic cells or form a local depot. Our previously developed cucumber-mosaic virus-derived nanoparticles termed (CuMV <sub>TT</sub> -VLPs) incorporating a universal Tetanus toxoid epitope TT830-843 were assessed for their draining kinetics using stereomicroscopic imaging. A nano-vaccine has been generated by coupling p33 epitope as a model antigen to CuMV <sub>TT</sub> -VLPs using bio-orthogonal Cu-free click chemistry. The CuMV <sub>TT</sub> -p33 nano-sized vaccine has been next formulated with the micron-sized microcrystalline tyrosine (MCT) adjuvant and the formed depot effect was studied using confocal microscopy and trafficking experiments. The immunogenicity of the nanoparticles combined with the micron-sized adjuvant was next assessed in an aggressive transplanted murine melanoma model. The obtained results were compared to other commonly used adjuvants such as B type CpGs and Alum. Our results showed that CuMV <sub>TT</sub> -VLPs can efficiently and rapidly drain into the lymphatic system due to their nano-size of ~ 30 nm. However, formulating the nanoparticles with the micron-sized MCT adjuvant of ~ 5 μM resulted in a local depot for the nanoparticles and a longer exposure time for the immune system. The preclinical nano-vaccine CuMV <sub>TT</sub> -p33 formulated with the micron-sized MCT adjuvant has enhanced the specific T cell response in the stringent B16F10p33 murine melanoma model. Furthermore, the micron-sized MCT adjuvant was as potent as B type CpGs and clearly superior to the commonly used Alum adjuvant when total CD8 <sup>+</sup> , specific p33 T cell response or tumour protection were assessed. The combination of nano- and micro-particles may optimally harness the physiological properties of the lymphatic system. Since the nanoparticles are well defined virus-like particles and the micron-sized adjuvant MCT has been used for decades in allergen-specific desensitization, this approach may readily be translated to the clinic
    corecore